<SEC-DOCUMENT>0001493152-22-011838.txt : 20220502
<SEC-HEADER>0001493152-22-011838.hdr.sgml : 20220502
<ACCEPTANCE-DATETIME>20220502172937
ACCESSION NUMBER:		0001493152-22-011838
CONFORMED SUBMISSION TYPE:	N-CSR/A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220502
DATE AS OF CHANGE:		20220502
EFFECTIVENESS DATE:		20220502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DAXOR CORP
		CENTRAL INDEX KEY:			0000027367
		IRS NUMBER:				132682108
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		N-CSR/A
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-22684
		FILM NUMBER:		22883457

	BUSINESS ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 4740
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118
		BUSINESS PHONE:		212-330-8500

	MAIL ADDRESS:	
		STREET 1:		350 5TH AVENUE
		STREET 2:		SUITE 4740
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IDANT CORP
		DATE OF NAME CHANGE:	19730823
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-CSR/A
<SEQUENCE>1
<FILENAME>formn-csra.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
filed with the Securities and Exchange Commission on May 2, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
</FONT></B><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Washington, D.C. 20549</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Amendment
No. 1 to</B></FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
N-CSR/A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFIED
SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
Company Act file number <B><U>811-22684</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B><U>Daxor
Corporation</U></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
(Exact name of registrant as specified in charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>109
Meco Lane</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Oak
Ridge, Tennessee 37830</U></B><BR>
(Address of principal executive offices) (Zip code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Michael
Feldschuh</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>109
Meco Lane</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Oak
Ridge, Tennessee 37830</U></B><BR>
(Name and address of agent for service)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>212-330-8500</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of fiscal year end: <B><U>December 31, 2021</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of reporting period: <B><U>December 31, 2021</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Explanatory
Note</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2022, the undersigned registrant filed its Certified Shareholder Report on Form N-CSR for the annual period ended December
31, 2021. The registrant hereby amends the original Certified Shareholder Report on Form N-CSR by (collectively, the &ldquo;<U>Supplemental
Disclosure</U>&rdquo;): (1) supplementing Item 1 of Form N-CSR, &ldquo;Reports to Stockholders,&rdquo; to file Rule 8b-16 disclosure
and additional disclosure around Daxor&rsquo;s performance; (2) amending and restating Item 11.(b) of Form N-CSR, &ldquo;Controls and
Procedures;&rdquo; (3) filing, under Item 13 of Form N-CSR, &ldquo;Exhibits,&rdquo; current certifications with updated language for
Item 4.(d) of the certification under Rule 30a-2(a) of the Investment Company Act; and (4) filing, under Item 13 of Form N-CSR, &ldquo;Exhibits,&rdquo;
the letter from the former independent registered public accounting firm indicating it agrees with the statements made by Daxor in response
to Item 304(a) of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
amendment does not reflect events occurring after the filing of the original Certified Shareholder Report on Form N-CSR for the annual
period ended December 31, 2021, and, other than providing the Supplemental Disclosure, does not modify or update the disclosures in the
original Certified Shareholder Report on Form N-CSR in any way.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Item
1. Reports to Stockholders.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
8b-16 Disclosure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
8b-16 under the Investment Company Act of 1940, as amended, requires that we disclose certain information to stockholders in our annual
report. That disclosure is included in this report as provided below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividend
Reinvestment Plan</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daxor
does not maintain a dividend reinvestment plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Information
Investment Objectives and Policies</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daxor&rsquo;s
investment objectives and policies are provided below. There have not been any material changes to the investment objectives and policies
that have not been approved by shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
objective is to support and expand our operating businesses, through organic growth (i.e., the rate of business expansion through internal
enhancement of the business and operations as opposed to mergers, acquisitions and takeovers). The company is not primarily engaged in
the business of investing, reinvesting, owning, holding or trading in securities. Funds in excess of the company&rsquo;s business needs
are placed in instruments designed to maximize capital preservation and assure liquidity. The foregoing policies may be changed without
a shareholder vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
concentrate our investments in the utility industry and have an investment policy that calls for a minimum of 80% of the company&rsquo;s
investment portfolio to consist of electric utility stocks. The Board of Directors has authorized this minimum to be temporarily lowered
to 70% when management deems it to be necessary. At least once a year, the company reviews its investment strategy, and more frequently
as needed, at board meetings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
investment portfolio primarily consists of electric utility companies which are publicly traded common and preferred stock. In addition
to receiving income from dividends from the securities held in the investment portfolio, we also have an investment policy of selling
puts on stocks that we are willing to own. Such options usually have a maturity of less than 1 year. The company will also sell covered
calls on securities within its investment portfolio. Covered calls involve stocks, which usually do not exceed 15% of the value of the
company&rsquo;s portfolio.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will, at times, sell naked or uncovered calls, as well as, engage in short sales as part of an income strategy, and to a lesser extent
a strategy to mitigate risk. Our net short position will usually amount to less than 15% of the company&rsquo;s portfolio value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
this time, investments in debt instruments and foreign securities are not a principal investment strategy, and we expect any such investments
to be minimal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management expects that our investment portfolio will continue to consist primarily of publicly traded common and preferred stocks of
electric utilities. The percentage of investments other than electric utilities is expected to remain at less than 20% of the investment
portfolio.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regard to the non-principal investments for the investment portfolio, we are flexible in how we may allocate our investments. We may
allocate the non-principal investments among the following types of securities, in proportions which reflect the judgment of our management
of the potential returns and risks of such securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stocks and other
    equity securities (including common stocks, preferred stocks, convertible preferred stocks, warrants, options and American Depository
    Receipts);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bonds and other debt securities
    (including U.S. Treasury Notes and Bonds, investment grade corporate debt securities, convertible debt securities and debt securities
    below investment grade); and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Money market instruments.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Principal
Risk Factors</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daxor&rsquo;s
principal risk factors are provided below. There have not been any material changes to the principal risk factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Investment
Portfolio Risks</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Market
Risks</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
of money is a risk of investing in the company. The net asset value of the company can be expected to change daily and you may lose money.
There is no guarantee that the performance of our investment portfolio will be positive over any period of time, either short-term or
long-term. Market risk may affect a single issuer, industry, sector of the economy, or the market as a whole.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
and international markets have experienced significant periods of volatility in recent years due to a number of economic, political and
global macro factors, including the impact of the coronavirus (COVID-19) as a global pandemic and related public health issues, the ongoing
military conflict between Russia and Ukraine, growth concerns in the U.S. and overseas, uncertainties regarding interest rates, trade
tensions and the threat of tariffs imposed by the U.S. and other countries. In particular, the spread of the novel coronavirus worldwide
has resulted in disruptions to supply chains and customer activity, stress on the global healthcare system, rising unemployment claims,
quarantines, cancellations, market declines, the closing of borders, restrictions on travel and widespread concern and uncertainty. Health
crises and related political, social and economic disruptions caused by the spread of the recent coronavirus outbreak may also exacerbate
other pre-existing political, social and economic risks in certain countries. It is not possible to know the extent of these impacts,
and they may be short term or may last for an extended period of time. These developments as well as other events, could result in further
market volatility and negatively affect security prices, the liquidity of certain securities and the normal operations of securities
exchanges and other markets, despite government efforts to address market disruptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Equity
Investments</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we invest in equity securities, fluctuations in the stock market in general, as well as in the value of particular equity securities
held by us, can affect the performance of our investment portfolio. The value of equity securities will fluctuate due to many factors,
including the past and predicted earnings of the issuer, the quality of the issuer&rsquo;s management, general market conditions, forecasts
for the issuer&rsquo;s industry and the value of the issuer&rsquo;s assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Industry
Concentration</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
concentrate our investments within the electric utility industry. Because of its narrow industry focus, the performance of our investment
portfolio is tied closely to and affected by developments in the electric utility industry, such as competition and weather. The electric
utility industry is also sensitive to increased interest rates because of the industry&rsquo;s capital intensive nature. Also, an increase
in interest rates could cause some electric utilities to decrease dividends paid to shareholders which would reduce our investment income.
The earnings of electric utility companies could also be negatively affected by power outages. Electric utilities operate in an environment
of federal, state and local regulations, and these regulations may disproportionately affect an individual utility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Short
Sale Risks</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
investment portfolio will suffer a loss if it sells a security short and the value of the security rises rather than falls. It is possible
that the investment portfolio&rsquo;s long positions will decline in value at the same time that the value of its short positions increase,
thereby increasing potential losses to the portfolio. Short sales expose our investment portfolio to the risk that it will be required
to buy the security sold short (also known as &ldquo;covering&rdquo; the short position) at a time when the security has appreciated
in value, thus resulting in a loss to the portfolio. The investment performance of our investment portfolio will also suffer if it is
required to close out a short position earlier than it had intended. In addition, our investment portfolio may be subject to expenses
related to short sales that are not typically associated with investing in securities directly, such as costs of borrowing. These expenses
may negatively impact the performance of the investment portfolio. Short positions introduce more risk to the investment portfolio than
long positions (purchases) because the maximum sustainable loss on a security purchased (held long) is limited to the amount paid for
the security plus the transaction costs, whereas there is no maximum attainable price of the shorted security. Therefore, in theory,
securities sold short have unlimited risk.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Put
and Call Options Risk</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
use of options involves investment strategies and risks different from those associated with ordinary portfolio securities transactions.
If a strategy is applied at an inappropriate time or market conditions or trends are judged incorrectly, the use of options may lower
the return on the investment. There can be no guarantee that the use of options will increase the return or income on an investment.
In addition, there may be an imperfect correlation between the movement in prices of options and the securities underlying them and there
may at times not be a liquid secondary market for various options. An abrupt change in the price of an underlying security could render
an option worthless. The prices of options are volatile and are influenced by, among other things, actual and anticipated changes in
the value of the underlying instrument, or in interest or currency exchange rates, including the anticipated volatility of the underlying
instrument (known as implied volatility), which in turn are affected by fiscal and monetary policies and by national and international
political and economic events, as will the performance of the issuer of the underlying instrument. As such, prior to the exercise or
expiration of the option, the Company is exposed to implied volatility risk, meaning the value, as based on implied volatility, of an
option may increase due to market and economic conditions or views based on the sector or industry in which issuers of the underlying
instrument participate, including company-specific factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
writing put options, the Company takes on the risk of declines in the value of the underlying instrument, including the possibility of
a loss up to the entire strike price of each option it sells, but without the corresponding opportunity to benefit from potential increases
in the value of the underlying instrument. When the Company writes a put option, it assumes the risk that it must purchase the underlying
instrument at a strike price that may be higher than the market price of the instrument. If there is a broad market decline and the Company
is not able to close out its written put options, it may result in substantial losses. By writing a call option, the Company may be obligated
to deliver instruments underlying an option at less than the market price. In the case of an uncovered call option, there <FONT STYLE="background-color: white">is
a risk of unlimited loss. When an uncovered call is exercised, the Company must purchase the underlying instrument to meet its call obligations
and the necessary instruments may be unavailable for purchase. When the Company writes a covered call option, it gives up the opportunity
to profit from a price increase in the underlying instrument above the strike price. If a covered call option that the Company has written
is exercised, the Company will experience a gain or loss from the sale of the underlying instrument, depending on the price at which
the Company purchased the instrument and the strike price of the option. The Company will receive a premium from writing options, but
the premium received may not be sufficient to offset any losses sustained from exercised options. In the case of a covered call, the
premium received may be offset by a decline in the market value of the underlying instrument during the option period. If an option that
the Company has purchased is never exercised or closed out, the Company will lose the amount of the premium it paid and the use of those
funds.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Operating
Company Risks</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
business is at an early stage of commercial development and we may struggle to generate significant commercial uptake in our products
with our current resources.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is at an early stage of commercial development. We have a base of installed devices or tests run at approximately 65 hospitals
and clinics and approximately 40,000 kits have been sold to clinicians. These sites are covered by a sales, marketing, technical, and
clinical support team of 12 individuals composed of employees and consultants. Investment in expanding these resources will be required
to reach larger target customers at hospitals and clinics across the country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, significant research and clinical studies on the potential benefits of blood volume analysis to guide therapeutic decisions
will be required to gain acceptance into the guidelines of care and for broader clinical adoption. There is no guarantee that these studies
will be successful or completed in a timely or cost-effective manner allowing the company to benefit commercially from their completion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will need additional capital to conduct our operations and develop our products, and our ability to obtain the necessary funding is uncertain.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have used a significant amount of cash and retained earnings since inception to finance the continued development and testing of our
BVA-100 system, and we expect to need additional capital resources in order to further commercialize the product as well as develop related
products and updates to our existing device.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be successful in maintaining operating cash flow, and the timing of our capital expenditures and other expenditures may impede
our commercialization efforts if not sufficient. If financing is not sufficient and additional financing is not available or available
only on terms that are detrimental to our long-term survival, it could have a material adverse effect on our ability to successfully
commercialize our technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
financing through strategic collaborations, public or private equity or debt financings or other financing sources may not be available
on acceptable terms for our operating company, or at all. Additional equity financing could result in dilution to our shareholders. Further,
if we obtain additional funds through arrangements with collaborative partners, these arrangements may require us to relinquish rights
to some of our technologies, product or products that we would otherwise seek to develop and commercialize on our own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
sufficient capital is not available, we may be required to delay, reduce the scope of or eliminate one or more of our research or product
development initiatives, any of which could have an adverse effect on our financial condition or business prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
financial reporting reflects our status as a closed-end investment fund with an operating medical device division whose financial performance
is not broken out in detail and reported on a regular basis as is the case with traditional operating companies. As a result, shareholders
could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our common
stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
seek detailed financial information in their investments and our reporting structure conforms to that of an investment fund. Investors
may become dissatisfied with the level of reporting detail that our current fund structure maintains and require greater transparency
in the future or lose confidence in the management resulting in a negative impact on the stock price. While the company intends to file
for a change of reporting structure in the future to a traditional operating company with the SEC as revenues from the operating division
increase whether that will be achievable and at what date remains unknown at this point in time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
our efforts to protect our intellectual property related to our technologies are not adequate, we may not be able to compete effectively
in our market and our business would be harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely upon a combination of patents, trade secret protection and confidentiality agreements to protect the intellectual property related
to our technologies. Any disclosure to or misappropriation by third parties of our trade secrets or other confidential information could
assist competitors in duplicating or surpassing our technological achievements, thus eroding the competitive advantage we may derive
from these patents or know-how.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
strength of patents in the medical diagnostic field involves complex legal and scientific questions and can be uncertain. The patent
applications we own may fail to result in issued patents in the United States or in foreign countries and existing patents on parts of
our technology have entered the public domain. Third parties may challenge the validity, enforceability or scope of any issued patents
we own or license or any applications that may issue as patents in the future, which may result in those patents being narrowed, invalidated
or held unenforceable. Even if they are unchallenged, our patents and patent applications may not adequately protect our intellectual
property or prevent others from developing similar products that do not fall within the scope of our patents. If the breadth or strength
of protection provided by the patents we hold or pursue is threatened, our ability to commercialize any product candidates with technology
protected by those patents could be threatened. Since patent applications in the United States and most other countries are confidential
for a period of time after filing, we cannot be certain at the time of filing that we are the first to file any patent application related
to our technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the protection afforded by patents, we seek to rely on trade secret protection and confidentiality agreements to protect
proprietary know-how that is not patentable, processes for which patents are difficult to enforce and any other elements of our discovery
platform and drug development processes that involve proprietary know-how, information or technology that is not covered by patents or
not amenable to patent protection. Although we endeavor that all of our employees and certain consultants and advisors to assign inventions
to us, and all of our employees, consultants, advisors and any third parties who have access to our proprietary know-how, information
or technology to enter into confidentiality agreements, our trade secrets and other proprietary information may be disclosed or competitors
may otherwise gain access to such information or independently develop substantially equivalent information. Further, the laws of some
foreign countries do not protect proprietary rights to the same extent or in the same manner as the laws of the United States. As a result,
we may encounter significant difficulty in protecting and defending our intellectual property both in the United States and abroad. If
we are unable to prevent material disclosure of the trade secret intellectual property related to our technologies to third parties,
we may not be able to establish or maintain the competitive advantage that we believe is provided by such intellectual property, which
could materially adversely affect our market position and business and operational results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be involved in lawsuits to protect or enforce our patent, which could be expensive, time-consuming and unsuccessful.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competitors
may infringe our patents. To attempt to stop infringement or unauthorized use, we may need to enforce one or more of our patents, which
can be expensive and time-consuming and distract management. If we pursue any litigation, a court may decide that a patent of ours or
our licensor&rsquo;s is not valid or is unenforceable, or may refuse to stop the other party from using the relevant technology on the
grounds that our patents do not cover the technology in question. Further, the legal systems of certain countries, particularly certain
developing countries, do not favor the enforcement of patents, which could reduce the likelihood of success of any infringement proceeding
we pursue in any such jurisdiction. An adverse result in any infringement litigation or defense proceedings could put one or more of
our patents at risk of being invalidated, held unenforceable, or interpreted narrowly and could put our patent applications at risk of
not issuing, which could limit our ability to exclude competitors from directly competing with us in the applicable jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interference
proceedings provoked by third parties or brought by the U.S. PTO may be necessary to determine the priority of inventions with respect
to our patents or patent applications or those of our licensors. An unfavorable outcome could require us to cease using the related technology
or to attempt to license rights to use it from the prevailing party. Our business could be harmed if the prevailing party does not offer
us a license on commercially reasonable terms, or at all. Litigation or interference proceedings may fail and, even if successful, may
result in substantial costs and distract our management and other employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unsuccessful in obtaining or maintaining patent protection for intellectual property in development, our business and competitive
position would be harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are seeking patent protection for some of our technology and future products. Patent prosecution is a challenging process and is not
assured of success. If we are unable to secure patent protection for our technology and product candidates, our business may be adversely
impacted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, issued patents and pending international applications require regular maintenance. Failure to maintain our portfolio may result
in loss of rights that may adversely impact our intellectual property rights, for example by rendering issued patents unenforceable or
by prematurely terminating pending international applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to seeking patents for some of our technology and product candidates, we also rely on trade secrets, including unpatented know-how,
technology and other proprietary information, to maintain our competitive position. We currently, and expect in the future to continue
to, seek to protect these trade secrets, in part, by entering into confidentiality agreements with parties who have access to them, such
as our employees, collaborators, contract manufacturers, consultants, advisors and other third parties. We also enter into confidentiality
and invention or patent assignment agreements with our employees and consultants. Despite these efforts, any of these parties may breach
the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies
for any such disclosure. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive
and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing
or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor,
we would have no right to prevent them, or those to whom they disclose the trade secrets, from using that technology or information to
compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position
would be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will have to hire additional executive officers and employees to expand our business. If we are unable to hire qualified personnel, we
may not be able to implement our business strategy.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loss of the services of any of our key product or business development employees could delay our product development programs and our
research and development efforts. We do not maintain key person life insurance on any of our officers, employees or consultants. In order
to develop our business in accordance with our business strategy, we will have to hire additional qualified personnel, including in the
areas of sales, physician education, manufacturing, clinical trials management, regulatory affairs, and business development. We will
need to raise sufficient funds to hire the necessary employees and have commenced our search for additional key employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
depend on key personnel for our continued operations and future success, and a loss of certain key personnel could significantly hinder
our ability to move forward with our business plan.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the specialized nature of our business, we are highly dependent on our ability to identify, hire, train and retain highly qualified
scientific and technical personnel for the research and development activities we conduct or sponsor. The loss of one or more key executive
officers, or scientific officers, would be significantly detrimental to us. In addition, recruiting and retaining qualified scientific
personnel to perform research and development work is critical to our success. Our anticipated growth and expansion into areas and activities
requiring additional expertise will require the addition of new management personnel and the development of additional expertise by existing
management personnel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements,
which could cause our business to suffer.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to the risk of employee fraud or other misconduct. Misconduct by employees could include intentional failures to comply with
regulations of governmental authorities, such as the FDA or the European Medicines Agency, or EMA, to provide accurate information to
the FDA or EMA, to comply with manufacturing standards we have established, to comply with federal, state and international healthcare
fraud and abuse laws and regulations as they may become applicable to our operations, to report financial information or data accurately
or to disclose unauthorized activities to us. Employee misconduct could also involve the improper use of information obtained in the
course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to
identify and deter employee misconduct, and the precautions we currently take and the procedures we may establish in the future as our
operations and employee base expand to detect and prevent this type of activity may not be effective in controlling unknown or unmanaged
risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure by our employees
to comply with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves
or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition
of significant fines or other sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we experience delays or difficulties in clinical outcome studies or lack the funding to conduct them, receipt of necessary outcome data
could be delayed or prevented.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trials using our BVA-100 depend upon the successful funding, enrollment, and initiation of studies in coordination with research institutions
and hospitals. The company does not have sufficient funds to fully sponsor as many outcome studies as may be warranted for adoption of
our diagnostic as a standard of care. As such, the company depends upon a combination of grants and research agreements with sponsoring
institutions for many of the studies that have been conducted with its technology and anticipates continuing to do so for the foreseeable
future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
and our suppliers are subject to extensive FDA regulation, which can be costly and time consuming and can subject us to unanticipated
business costs or difficulties. Even though regulatory approval for products may have been granted, those products may still face regulatory
difficulties.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our current and potential products, as well as those supplied to Daxor by third parties, processing and manufacturing activities,
are subject to comprehensive regulation by the FDA in the United States and by comparable authorities in other countries. The company
has spent considerable resources and time obtaining FDA and other required regulatory approvals but is still subject to regulatory action
from the FDA if it chooses to revoke or enforce an interpretation of the regulations that would make distribution or manufacture of our
products disallowed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we, or third-party manufacturers we may contract with, violate regulatory requirements at any stage the FDA may take enforcement action(s)
against us, which could include issuing a warning or untitled letter, placing a clinical hold on an ongoing clinical trial, product seizure,
enjoining our operations, refusal to consider our applications for pre-market approval, refusal of an investigational new drug application,
fines, or even civil or criminal liability, any of which could materially harm our reputation and financial results. In addition, if
manufacturing problems occur, regulators may withdraw their approval or demand additional changes in product manufacture or marketing
practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enforcement
actions we and our suppliers are subject to include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">warning letters or other
    actions requiring changes in product manufacturing processes or restrictions on product marketing or distribution;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product recalls or seizures
    or the temporary or permanent withdrawal of a product from the market;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspending any ongoing
    clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">temporary or permanent
    injunctions against our production operations; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fines, restitution or disgorgement
    of profits or revenue, the imposition of civil penalties or criminal prosecution.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
occurrence of any of these actions would likely cause a material adverse effect on our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
difficulties or failures that we encounter regarding regulatory approval for our products or those of third-party suppliers would likely
have a substantial adverse impact on our ability to generate product sales, and could make any search for a collaborative partner more
difficult.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>For
some of our products, we currently lack sufficient manufacturing capabilities to produce our products in-house and rely upon third party
suppliers. Disruption in our manufacturing supply, could negatively impact our ability to meet any future demand for the product.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that we would need to significantly expand our manufacturing capabilities to meet potential demand for our diagnostic devices
and Volumex kits. In addition, we depend upon a single manufacturer for components of our products and a disruption in that supply could
materially impact our business disrupting out ability to meet demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently manufacture our BVA-100 device in a 20,000 square foot facility in Oak Ridge, Tennessee. If our facilities where our products
are currently being manufactured or equipment were significantly damaged or destroyed, or if there were other disruptions, delays or
difficulties affecting manufacturing capacity, including if such facilities are deemed not in compliance with current Good Manufacturing
Practice, or GMP, requirements, future clinical studies and commercial production for our products would likely be significantly disrupted
and delayed. It would be both time-consuming and expensive to replace this capacity with third parties, particularly since any new facility
would need to comply with the regulatory requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ultimately,
if we are unable to supply our products to meet commercial demand, whether because of processing constraints or other disruptions, delays
or difficulties that we experience, our production costs could dramatically increase and sales of our products and their long-term commercial
prospects could be significantly damaged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>To
be successful, our diagnostic products must be broadly accepted by the healthcare community, which can be very slow to adopt or unreceptive
to new technologies and products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
products that we manufacture represent substantial departure from more established methods of volume assessment and compete with a number
of more conventional therapies based upon measures of pressure or hemodynamics manufactured and marketed by major medical device companies.
The degree of market acceptance and uptake of our products depends on a number of factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our establishment and demonstration to the medical
    community the clinical efficacy and safety of our proposed products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to demonstrate that our products are superior
    to alternatives currently on the market in accuracy and ease of use;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to establish in the medical community the
    potential advantage of our diagnostic over alternative diagnostic methods; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reimbursement policies of government and third-party
    payers.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the healthcare community does not accept our products for any of these reasons, or for any other reason, our business would be materially
harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
competition includes diagnostic companies that have significant advantages over us.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for medical diagnostic products is highly competitive. We expect that our most significant competitors will be fully integrated
and more established medical device companies with extensive product lines and distribution networks. These companies may seek to develop
similar products, and they have significantly greater capital resources and research and development, manufacturing, testing, regulatory
compliance, and marketing capabilities. As a result, our competitors may develop more competitive or affordable products, or achieve
earlier patent protection or product commercialization than we are able to achieve. Competitive products may render our products or future
products that we develop obsolete.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be subject to litigation that will be costly to defend or pursue and uncertain in its outcome.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business may bring us into conflict with our licensees, licensors or others with whom we have contractual or other business relationships,
or with our competitors or others whose interests differ from ours. If we are unable to resolve those conflicts on terms that are satisfactory
to all parties, we may become involved in litigation brought by or against us. That litigation is likely to be expensive and may require
a significant amount of management&rsquo;s time and attention, at the expense of other aspects of our business. The outcome of litigation
is always uncertain, and in some cases could include judgments against us that require us to pay damages, enjoin us from certain activities,
or otherwise affect our legal or contractual rights, which could have a significant adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are exposed to the risk of liability claims, for which we may not have adequate insurance.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
we participate in the health care industry, we may be subject to liability claims by employees, customers, end users and third parties
for past products and services as well as current or future products. While the company carries liability insurance there can be no assurance
that the liability insurance we carry will be adequate to cover claims asserted against us or that we will be able to maintain such insurance
in the future</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
currently have a marketing and sales force of approximately 12 employees and consultants. If we are unable to establish effective marketing
and sales capabilities or enter into agreements with third parties to market and sell our product candidates, we may not be able to effectively
market and scale our sales to a significant scale.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have a marketing and sales team for the marketing, sales and distribution of our BVA-100 device and kits. In order to fully
commercialize our products, we must expand our territory-by-territory basis marketing, sales, distribution, managerial and other non-technical
capabilities or make arrangements with third parties to perform these services, and we may not be successful in doing so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
failure or delay in the further development of our internal sales, marketing and distribution capabilities would adversely impact the
commercialization of any of our products that we obtain approval to market. We may choose to collaborate, either globally or on a territory-by-territory
basis, with third parties that have direct sales forces and established distribution systems, either to augment our own sales force and
distribution systems or in lieu of our own sales force and distribution systems. If we are unable to enter into such arrangements when
needed on acceptable terms or at all this will adversely affect our ability to rapidly scale the sale of our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
business and operations would suffer in the event of system failures or natural and man-made disasters.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
the implementation of security measures, our internal computer systems and those of our contractors and consultants are vulnerable to
damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. While
we have not experienced any such system failure, accident or security breach to date, if such an event were to occur and cause interruptions
in our operations, it could result in a material disruption of our operations. For example, a hurricane or severe flood could disrupt
one of our key suppliers disrupting our supply chain for weeks or months causing material losses. If any disruption or security breach
resulted in a loss of or damage to our data or applications, or inappropriate disclosure of confidential or proprietary information,
we could incur liability and additional costs despite some insurance products that the company has purchased to mitigate such costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have incurred net operating losses in the past, and may incur them in the future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred cumulative net operating losses in the past. These losses have mainly resulted from ongoing expenses for marketing and
research and development as the company attempts to build a market for its products. In the past, the company&rsquo;s cumulative net
income from investments and other items exceeded the operating losses and provided the necessary funds for its continued research and
development and marketing. It is the opinion of management that the financial health of the company would have been adversely affected
if net income from investments had been substantially less than losses from operations. There is no guarantee that future net income
from investments will continue to completely offset operating losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
loss of any one customer could have an adverse effect on our consolidated operating business for a short period of time.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the past, the sale of Blood Volume Kits has accounted for a significant portion of the company&rsquo;s total consolidated operating revenue,
and a small number of customers (hospitals) has comprised the majority of such sales. Management believes that the loss of any one customer
would have an adverse effect on our consolidated operating business for a short period of time. The company continues to seek new customers,
so that any one hospital will represent a smaller percentage of overall sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
there is a decrease in the market value of our available for sale securities, this could have an adverse effect on our ability to fund
research and development and marketing efforts.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2021, 92.87% of the fair market value of Daxor Corporation&rsquo;s investment in securities consisted of utility stocks
whose market price can be sensitive to rising interest rates. The company&rsquo;s investment policy calls for a minimum of 80% of the
investment portfolio to consist of electric utility stocks. At December 31, 2021, 91.96% of the fair market value of Daxor Corporation&rsquo;s
investment in securities consisted of electric utility stocks. The Board of Directors has authorized this minimum to be temporarily lowered
to 70% when management deems it to be necessary. Investments in utilities are primarily in electric companies. Investments in non-utility
stocks will generally not exceed 20% of the value of the portfolio of investment securities. Given the current volatility in the market,
management feels this is a temporary situation. Depending on the duration of the current market conditions the Board of Directors will
revisit this investment policy. At December 31, 2021, the fair market value of Daxor Corporation&rsquo;s investment in securities was
36.49% of total net assets. The investment in the Operating Company and other assets and liabilities was the remaining balance of the
portfolio.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2021, the company&rsquo;s investment portfolio consisted of 22 separate investments in common stocks and 1, preferred stock..
The top five holdings as of this date in the investment portfolio were DTE Energy Company, First Energy Corporation, Entergy Corporation,
NiSource Corporation and Evergy Inc. . These five holdings comprised 44.29%% of the value of the investment in securities portfolio and
accounted for 43.42% of the dividend income for the year ended December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is a risk that in an environment of rising interest rates that the market value of these stocks could decline and the utilities could
reduce their dividend payments to compensate for increased interest expense. This could have an adverse effect on Daxor Corporation&rsquo;s
ability to fund research and development and marketing efforts necessary to build a market for the company&rsquo;s products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
absence of patents or the inability to defend patents could negatively impact our ability to compete for and obtain new business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daxor
Corporation&rsquo;s patents for the BVA 100 expired in 2010. The company filed two additional patent applications for an automated instrument
to measure human blood volume which were granted April 7, 2015. The filings describe innovations which will be or have been incorporated
into the company&rsquo;s BVA-100 Blood Volume Analyzer, these patents expanded the capabilities of the analyzer to incorporate total
body albumin measures and error correction software to improve accuracy. In addition, the company filed additional patents on its blood
volume technology in January of 2018, and has several more patents in various stages of development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
blood volume analyzer, however, works most efficiently with the tracer injection kit system which has a separate patent and which expired
in 2016. It is possible that another company could develop another version of the Blood Volume Analyzer which would use a different tracer
injection kit. To the best of the company&rsquo;s knowledge, this has not happened yet and management views the development of a competing
tracer injection kit as unlikely.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
the current manufacturer were to cease filling the Volumex syringes for us for any reason before we had a chance to make alternative
arrangements, this could have a material negative impact on our operating revenue.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of Daxor Corporation&rsquo;s orders for Volumex syringes are filled by a single FDA inspected radio pharmaceutical manufacturer. If this
manufacturer were to cease filling the Volumex syringes for the company or were denied permission to do so by FDA for any reason before
the company had a chance to make alternative arrangements, the effect on the company&rsquo;s operating revenue could be material. In
January 2007, we purchased two 10,000 square foot buildings in Oak Ridge, Tennessee to expand its research, development, and manufacturing
capabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Charter
or By-laws</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no changes to Daxor&rsquo;s charter or by-laws that would delay or prevent a change of control of Daxor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Persons
Responsible Management</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no changes in the persons who are primarily responsible for the day-to-day management of Daxor&rsquo;s operations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Management
Discussion of Fund Performance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
Letter to Shareholders for a more fulsome discussion of Daxor&rsquo;s performance during the fiscal year ended December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
below graph illustrates the hypothetical growth of $10,000 based upon the performance of Daxor&rsquo;s common share price (&ldquo;<U>Daxor
Market Price</U>&rdquo;) and net asset value per share price (&ldquo;<U>Daxor NAV</U>&rdquo;) for the 9-year period ended December
31, 2021 as compared to the Standard &amp; Poor&rsquo;s 500<SUP>&reg;</SUP> Index. A 9-year period is shown, as Daxor has been reporting
as an investment company since January 1, 2012. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than that shown
based on market fluctuations from the end of the reported period. The table and graph do not reflect any deduction for taxes that a shareholder
may pay on distributions or the disposition of Daxor shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Index
performance is shown for illustrative purposes only and does not reflect any fees, expenses or sales charges. It is not possible to invest
directly in an index. The Standard &amp; Poor&rsquo;s 500<SUP>&reg; </SUP>Index consists of 500 selected common stocks, most of which
are listed on the NYSE. The Standard &amp; Poor&rsquo;s Ratings Group designates the stocks to be included in the Index on a statistical
basis. A particular stock&rsquo;s weighting in the Index is based on its relative total market value (<I>i.e.</I>, its market price per
share times the number of shares outstanding.) Stocks may be added or deleted from the Index from time to time. A direct investment in
an index is not possible. The S&amp;P 500<SUP>&reg; </SUP>Index is a trademark of Standard &amp; Poor&rsquo;s Financial Services LLC.
The index is used herein for comparative purposes in accordance with SEC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formncrsa_001.jpg" ALT="" STYLE="height: 308px; width: 480px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%; margin-left: 0.5in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid"> Average Annual Returns </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> 1 Year </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> 5 Year </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> 9 Year </TD><TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"> Return </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"> Return </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"> Return </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%"> NAV </TD><TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 14%; text-align: right"> 34.70 </TD><TD STYLE="width: 1%; text-align: left"> % </TD><TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 14%; text-align: right"> 5.34 </TD><TD STYLE="width: 1%; text-align: left"> % </TD><TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 14%; text-align: right"> -5.23 </TD><TD STYLE="width: 1%; text-align: left"> % </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> Stock </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> -9.76 </TD><TD STYLE="text-align: left"> % </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 6.64 </TD><TD STYLE="text-align: left"> % </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 4.81 </TD><TD STYLE="text-align: left"> % </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> S&amp;P </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 28.71 </TD><TD STYLE="text-align: left"> % </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 18.48 </TD><TD STYLE="text-align: left"> % </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 16.61 </TD><TD STYLE="text-align: left"> % </TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Item
11. Controls and Procedures.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
There were no changes in the registrant&rsquo;s internal control over financial reporting that occurred during the period covered by
this report that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over
financial reporting other than the above mentioned corrective steps to improve the timeliness of the financial reports as required under
the Investment Company Act of 1940.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Item
13. Exhibits.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(a)</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) <I>Code
    of ethics, or amendments thereto, that is the subject of the disclosure required by Item 2, to the extent that the registrant intends
    to satisfy Item 2 requirements through filing of an exhibit.</I> - Previously filed.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex13a2.htm">(2) <I>A separate certification for each principal executive and principal financial officer pursuant to Rule 30a-2(a) under the Act and Section 302 of the Sarbanes-Oxley Act of 2002.</I></A> - <B>Filed herewith</B>.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
<I>Any written solicitation to purchase securities under Rule 23c-1 under the Act sent or given during the period covered by the report
by or on behalf of the registrant to 10 or more persons. </I>Not applicable to open-end investment companies.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A HREF="ex13a4.htm">(4) <I>Change in the registrant&rsquo;s independent public accountant. Provide the information called for by Item 4 of Form 8-K under the Exchange Act. Unless otherwise specified by Item 4, or related to and necessary for a complete understanding of information not previously disclosed, the information should relate to events occurring during the reporting period.</I></A> &ndash; <B>Filed herewith</B>.</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(b)</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><A HREF="ex13b.htm">Certifications pursuant to Rule 30a-2(b) under the Act and Section 906 of the Sarbanes-Oxley Act of 2002.</A> - </I><B>Furnished herewith</B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DAXOR
    CORPORATION</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael Feldschuh</I></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Feldschuh</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2,
    , 2022</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below
by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Michael Feldschuh</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Feldschuh, President and</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer (Principal Executive Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    2, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Robert J. Michel</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    J. Michel, Chief Financial Officer and</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Compliance Officer (Principal Financial Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    2, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.A2
<SEQUENCE>2
<FILENAME>ex13a2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
13(a)(2)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Michael Feldschuh, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this amended report on Form N-CSR/A of Daxor Corporation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required
    to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    am responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment
    Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act
    of 1940) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about
    the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report
    based on such evaluation; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the period covered
    by this report that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control
    over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have disclosed to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons
    performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize, and report financial information;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael Feldschuh </I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Feldschuh</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    (Chief Executive Officer, Principal Executive Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
May 2, 2022<BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
13(a)(2)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Robert J. Michel, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this amended report on Form N-CSR/A of Daxor Corporation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required
    to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    am responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment
    Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act
    of 1940) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about
    the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report
    based on such evaluation; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the period covered
    by this report that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control
    over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have disclosed to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons
    performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize, and report financial information;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Robert J. Michel </I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    J. Michel</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer (Chief Principal Financial Officer/Principal Accounting Officer/Chief Compliance Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
February 24, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.B
<SEQUENCE>3
<FILENAME>ex13b.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
13(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
and (b) of section 1350, chapter 63 of title 18, United States Code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the attached report of Daxor Corporation on amended Form N-CSR/A to be filed with the Securities and Exchange Commission
(the &ldquo;Report&rdquo;), the undersigned officer of the Corporation does hereby certify that, to the best of such officer&rsquo;s
knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Report fully complies with the requirements of 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company as of, and for, the periods presented in the Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
certification is furnished as an exhibit solely pursuant to Item 13(b) of amended Form N-CSR/A and is not deemed to be &ldquo;filed&rdquo;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.
This certification is not deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended or the
Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically incorporates this certification by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael Feldschuh</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Feldschuh</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    (Chief Executive Officer, Principal Executive Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
May 2, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
13(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
and (b) of section 1350, chapter 63 of title 18, United States Code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the attached report of Daxor Corporation on amended Form N-CSR/A to be filed with the Securities and Exchange Commission
(the &ldquo;Report&rdquo;), the undersigned officer of the Corporation does hereby certify that, to the best of such officer&rsquo;s
knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Report fully complies with the requirements of 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company as of, and for, the periods presented in the Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
certification is furnished as an exhibit solely pursuant to Item 13(b) of amended Form N-CSR/A and is not deemed to be &ldquo;filed&rdquo;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.
This certification is not deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended or the
Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically incorporates this certification by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Robert J. Michel</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    J. Michel</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer (Chief Principal Financial Officer/Principal Accounting Officer/Chief Compliance Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
May 2, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.A4
<SEQUENCE>4
<FILENAME>ex13a4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 13 (a) (4)</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex13a4_001.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>formncrsa_001.jpg
<TEXT>
begin 644 formncrsa_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $U >$# 2(  A$! Q$!_\0
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M^^11]F@_YXQ_]\BI:* (OLT'_/&/_OD4?9H/^>,?_?(J6B@"+[-!_P \8_\
MOD4?9H/^>,?_ 'R*EHH YK<?4T4E% '0VW_'K#_N#^52U%;?\>L/^X/Y5+0
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M(3^])_W\;_&I:* (O(3^])_W\;_&CR$_O2?]_&_QJ6B@!%4*H S@>IS2T44
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M+10!%]I@_P">T?\ WT*/M,'_ #VC_P"^A4M% $7VF#_GM'_WT*/M,'_/:/\
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M/S7_ !H EHJ+S7_Y]Y/S7_&CS7_Y]Y/S7_&@"6BHO-?_ )]Y/S7_ !H\U_\
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M4EN06$J."I [Y'%0#6=+-D;T:E9FU#;3/YZ[ WINSC- %Q$6-%1%"JHP% P
M/2EIJ.DL:R1LKHP#*RG((/0@TZ@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P ](_\ OV?\:EHH BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&I:* (ML_\
MSTC_ ._9_P :-L__ #TC_P"_9_QJ6B@"+;/_ ,](_P#OV?\ &C;/_P ](_\
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M;^\(R%'Z_P#UJ:FC:CJSB75[@QQ=1;QGI]?\DUO6MG;V47E6T2QK[#K]3WH
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MR#%P('\L)LW?<WYW9!'WL=_:@#HJ*IZ5=O?:9!<RJJRLN'"]-P.#CVR#BKE
M!147VF#_ )[1_P#?0H^TP?\ /:/_ +Z% $M%1?:8/^>T?_?0H^TP?\]H_P#O
MH4 2T5%]I@_Y[1_]]"C[3!_SVC_[Z% $M%1?:8/^>T?_ 'T*/M,'_/:/_OH4
M 2T5%]I@_P">T?\ WT*/M,'_ #VC_P"^A0!+147VF#_GM'_WT*/M,'_/:/\
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M?_GWD_-?\:/-?_GWD_-?\:EHH B\U_\ GWD_-?\ &CS7_P"?>3\U_P :EHH
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MC;/_ ,](_P#OV?\ &CZLW\<V_G;\@^M)?!"*^5_S.<_X1"2X_P"/_5[NXSU
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M="L=WOF&URN6CVC:#C/4]J%J!KT5BS:\\-X^ZT7[ D_V=[CS?G#[<_<V\KG
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M?9BPL(;4.9/+7!<C!8]2<=LDFK-%% $7D)ZR?]_&_P :/(3^])_W\;_&I:*
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M8/\ GM'_ -]"C[3!_P ]H_\ OH5+10!%]I@_Y[1_]]"C[3!_SVC_ .^A4M%
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M+10!%]I@_P">T?\ WT*/M,'_ #VC_P"^A4M% "*RLH92"#T(-+110!S-%%%
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M_IA_X_\ _6HHH /[7_Z8?^/_ /UJ/[7_ .F'_C__ -:BB@ _M?\ Z8?^/_\
MUJ/[7_Z8?^/_ /UJ** #^U_^F'_C_P#]:C^U_P#IA_X__P#6HHH /[7_ .F'
M_C__ -:C^U_^F'_C_P#]:BB@ _M?_IA_X_\ _6H_M?\ Z8?^/_\ UJ** #^U
M_P#IA_X__P#6H_M?_IA_X_\ _6HHH /[7_Z8?^/_ /UJ/[7_ .F'_C__ -:B
MB@ _M?\ Z8?^/_\ UJ/[7_Z8?^/_ /UJ** #^U_^F'_C_P#]:C^U_P#IA_X_
M_P#6HHH /[7_ .F'_C__ -:C^U_^F'_C_P#]:BB@ _M?_IA_X_\ _6H_M?\
MZ8?^/_\ UJ** #^U_P#IA_X__P#6H_M?_IA_X_\ _6HHH /[7_Z8?^/_ /UJ
M/[7_ .F'_C__ -:BB@ _M?\ Z8?^/_\ UJ/[7_Z8?^/_ /UJ** #^U_^F'_C
M_P#]:C^U_P#IA_X__P#6HHH /[7_ .F'_C__ -:C^U_^F'_C_P#]:BB@ _M?
M_IA_X_\ _6H_M?\ Z8?^/_\ UJ** #^U_P#IA_X__P#6H_M?_IA_X_\ _6HH
)H S<4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex13a4_001.jpg
<TEXT>
begin 644 ex13a4_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ER!TH# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD0))<0AW5>@;OCVS6G7F2BXMQ?0[XM22:"BBBD,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BN2U[Q+>Z=JKVMND.Q%4Y=2221GUK6U35)K7PZ+^%5$K(A (R!NQ_C5
M<KT.98NFW-+[.YKT5S7AC7+O59[B.ZV$(H92JX[UTM)JSL:4:T:T%..P4444
MC4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OEGQ!_R,
MFJ?]?<O_ *&:^IJ\=USX1:O>:Y>W=C?6/V>>9I5$S.K#<<X.%(XSZUZF5UZ=
M*<O:.UT>?F%*=2,>17L>55T7@/\ Y'K1_P#KX'\C71_\*9\1?\_NE_\ ?V3_
M .(K9\*?"O5M'\26>HWUY9&&W??M@9V9CC@<J!7JUL;AW3DE-;/^MCSJ6$K*
MI%N+W1ZS1117RQ]"8_BG5I="\,7^IP(CS01Y17^[DD 9_.O&?^%M>*?^>UK_
M -^!7JWQ%_Y$#5O^N:_^AK7SA7NY7AZ52DW.*;O^AY&85JD*B47;0[G_ (6U
MXI_Y[6O_ 'X%>C_#;Q;J'BFQO3J*Q>;;2* \:[=P8'J/;%?/]>P_!/\ X\]9
M_P"ND7\FK7,,-1AAW*,4GI^9E@J]6591E)M:GJU%%%?.GN!7C'QJ_P"0QI?_
M %[M_P"A5[/7C'QJ_P"0QI?_ %[M_P"A5Z&6?[ROG^1Q9A_ ?R/+Z***^H/G
MSZ5\!_\ (BZ/_P!>X_F:Z*N=\!_\B+H__7N/YFNBKXRO_%EZO\SZFC_#CZ+\
M@HHHK(T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BN*\2:WJ-GK,D%O<&.)57 "CN,]Q61_P
MDNL?\_K_ /?*_P"%6J;:N>;4S.E3FX-/0F\6?\C#/_NI_P"@BNAUS_D2H_\
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M%%%%<1UG)WOQ)\+6%[-:3:@QEB8H^R%V (ZC(&#4'_"U/"7_ #_2_P#@._\
MA7@-W_Q^3_\ 71OYU#7T:RBA;5O^OD>&\RJWT2/I31O'7A[7K\6-A?%KE@65
M'C9-V.N,CD^U='7SA\.O^1_TG_KHW_H#5]'UY6/PT,/448;-'HX.O*M!REW,
MW6M>TWP]9"[U.X$,18(OREBS>@ YKGO^%J>$O^?Z7_P'?_"L+XU?\@?2_P#K
MX;_T&O&*Z\%E]*M152;=SEQ6-J4JKA%(^A/^%J>$O^?Z7_P'?_"NIT[4;35K
M"*^L9UFMI1E'7OV/7H<U\I5ZAX9\=V?A;X=I%'MN-3:>01V^>%S_ !-[?S_4
M5BLKC"*=&[=Q8?,'*3]K9*QZSJFLZ=HMM]HU*\BMH^Q=N6^@ZD_2N(O?C'H$
M#LEK:WMSC^,*J*?IDY_2O&M5U:^UJ^>]U"Y>>=^['@#T Z >PJE6U'**:7[Q
MW?W(RJYE4;_=JR/;(/C1H[/B?3;V-?5"K?ID5UNA^,M!\0D)I]^C3XSY$@*/
M^ /7\,U\S4Y'>*17C9D=3E64X(/J*NIE-&2]RZ?WDPS*JG[VJ/K6BO-/AY\1
M!J5N^FZY<QI=0)NCN96"B5!U#$_Q#]1].>;\;?$^ZU.673]#E>WL1E6N%XDF
M^G]U?U/Z5Y,<OK2JNE;;KT/1EC:2IJI??IU/3M:\<>'M!9H[S4$,Z]881YC@
M^A Z?CBN5G^-&CJ^(--OI%]7V+_4UXG17K4\IH17O7;^X\Z>95F_=LCV^V^,
MVB2,!<6%]#G^)0K@?J*[#1?%.B^(5SIM_',X&3$<JX_X">?QKY@J2">6VG2>
M"5XI4.Y'1BK*?4$=*57*:,E[C:?WCIYE53]]71]9T5P7PY\=-XDMVT_467^T
MX%W;P,"9/7'J._Y^N.]KP:U&5&;A/='L4JL:L5..QCZGK.E6-T(;Q=TNT'_5
M[L"J?_"2Z!_SR_\ ( J75_#$>JWWVHW31$J%*[,]/QJA_P (+'_S_O\ ]^A_
MC4KEMJ<%5XSG?)%6Z;%K_A)= _YY?^0!6U-J%K%IIOG?-MM#;@,Y!Z<?C7F^
ML::=*U![7S/,  8-C'!KJ[[_ ))^O_7&+_T):;BM+&=#%U7[1323BOQ)O^$J
MT7T?_OU1_P )5HOH_P#WZKE="T;^V;B6,S>4L:[B0N2>:W?^$%C_ .?]_P#O
MT/\ &FU%;D4J^-JQYX15OE_F;FF:S8:D[QVA(9!N*E-O'K6E6+HOAV/1IY)E
MN&E9UV\K@ 9S6U6;M?0]3#NJZ:]JK,****1L%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4445)U!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC'QJ_P"0QI?_ %[M_P"A5[/7C'QJ_P"0QI?_ %[M_P"A5Z&6?[ROG^1Q9A_
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M]!KQBO9_C5_R!]+_ .OAO_0:\8KTLL_W9?/\S@S#^._D%>[_  ?M8X?!TDX
M\R>Z<L>^   /Y_G7A%>_?"7_ )$6+_KXD_G49L_]G^:+RU?O_DSN:***^:/>
M/&/C5;(FL:7<C[\D#(WT5LC_ -"->7UZM\;/^/S1O^N<O\UKRFOJ\O=\-#^N
MK/G,:OW\@KZ$^%EHMMX"LW"X:X>25_<[RH_117SW7T?\.O\ D0-)_P"N;?\
MH;5SYN_W"7G_ )F^6+]ZWY'44445\X>X>&?&.V2'Q;;SH,&>T4O[D,PS^6/R
MKSNO2OC1_P C)I__ %Z?^SM7FM?6X%WPT/3_ #/FL8K5Y>H5]->#/^1*T;_K
MTC_]!KYEKZ:\&?\ (E:-_P!>D?\ Z#7%G'\./K^AUY7_ !)>GZF[1117SY[0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRS_>8_/\CGQ_^[OY?F>4T445]2?/'T?\.O\ D0-)_P"N;?\ H;5U%<O\.O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!F'\=_(*]^^$O_(BQ?\ 7Q)_.O :]^^$H(\"Q9'6>3'YU&;?[O\ -?J7EO\
M&^3.YHHHKYH]X\>^-G_'YHW_ %SE_FM>4UZM\;0?M>C''&R7G\5KRFOJ\N_W
M:/\ 75GSF._WB7]= KZ/^'7_ "(&D_\ 7-O_ $-J^<*^C_AU_P B!I/_ %S;
M_P!#:N;./X,?7]#?+/XK]#J****^=/</$OC1_P C)I__ %Z?^SM7FM>E_&@'
M_A(]//;[)_[.U>:5];@/]VAZ?YGS>,_CR]0KZ:\&?\B5HW_7I'_Z#7S+7TWX
M,_Y$K1O^O./_ -!KBSC^''U_0ZLK_B2]/U-RBBBOGSV@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH XF?X5>%IYY)?L]PF]BVU)B ,^GM3/\ A4OA;_GE=?\
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M16$IRF[R=V:QBHJT58YF]^'OA6_NY+JXTA#-*VYRDLB GN<*P%5_^%8^#_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17 7?B?4(OB!$5
MD/\ 84=PNF2>AN&4MGZ@E17?UK4I2IVOU5S.G44[VZ!17G?AN#Q5XH\+VNIO
MXNEMVGWG8EC%\I5V4<@ G[M;OA'6-2NYM3TC6?+?4=,E1))HUVK*C@E6QV)
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MX-O;F]_X2#[3/)-Y.M7,,6]L[$&W"CT S4<5]=GXJSV!N)#:#21*(=WRA_,
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M'4+GS0A]0,#GCO54ZE)<DV]8]+>;>XIPJ/GBEI+K?R2V(/B0AC^&FH1G&56
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0CMQ0M8W>EU=?=<;=G9:V=OZ]!_PI\1ZKXET35;C5[K[3+!J<L$;>6J;44#
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M,H/]:\U^.F9=%\/6DA_T2XUB))_0K@]:)J2?)LVTOO=A1DN7GZ6O^%RE!?\
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M<_=O;6RO^%SW^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M->ET4):6>ME9?=;7O9!)7;MU=_U/+O@;_P BWKG_ &&9_P"2U)9?\G%:G_V
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M[4+N*Y^48)'J."3SVQ7N-%3!<MKZ\NWRVOZ#DKWMUW^>_P!YYC>_\G&Z=_V
MW_\ 0VJ+XZ?\B[H7_89@_DU>IT4)645V=_\ R:XWJY/NK?\ DMO^"':BBBF
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 445YSJ?Q4LQ\0]'\*:*UO>-/.8[Z?)98A@_*I!QNR.>H
M'3KT%K)1ZL'HG)[(]&HK/US6;3P_H=YJU\Q6VM8C(^.IQV'N3Q7E"_$?XG7-
MF=>M/ MN=!VF0*\A\]DQG(^<$\<\(:7,K^@6/9Z*PO#OBNP\0^$8/$<1\FUD
MA:20.<F+;G<#],&O.(_B3\0_$._4_"G@N"?0T<A9;I\23*#U7+KZ=@V/>F])
M.+Z"335T>R45S'@/QE%XV\/?V@+5K2ZAE:"ZMG.3%(O4=OU%=/3:L"=PHKQ@
M>/\ XH:OKVMVOAKP[HU[9Z=>R6IDD.QA@G&=TRY.!V&*T+#7OC3)J-LE]X1T
M6*T:51/(DJY5,C<1_I!YQGL:4?>M;K^HY>[?R/5Z**XWQYX\_P"$1^PV-CIL
MNJ:UJ+%;2SC.,XZLQ].?_P!76DW8#LJ*\@;QG\7M.5[[4_ EC+IZ NT=M,/-
M"]>TC$G'^S7HGA?Q18>+/#<&MV&\0R*=T;?>C8?>4^XI]&^PKZV[FW17.^"_
M%<7C/0FU>WMGMX3/)$B2$%B%.,G' )]*Z*BUAA1110 4444 %%<[XE\60^'=
M0T2Q:V>:;5KL6T9! 5.F6/X'@?RKHJ%JKAUL%%%<1\4_&6H>!O"D>JZ;!:S3
M-=)"5N59EVD,3]U@<\4FTMQI-NR.WHK"\'^*+/QAX:M=8LR )5Q+'GF*0?>4
M_0_IBLW4_%5]9?$[1?#4<5N;*^M)9Y'96\P,N<8.<8X[@U35I<KW_P"!?]"%
M)./-T_I'7T45YQ\1?&GBG0/$>B:+X6TZPOKK4DE81W0.24P>#O4#C/6IOJEW
M_K]"NEST>BO'_P#A(?CG_P!"9H?_ '^7_P"2*[_P;>>*+W1#+XMTZUL-2\U@
M(;9@R[.,'AWYZ]ZJPF['0T444AA1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 5-4TZ'5]*NM.N&D6&YB:)S&VUMI&#@]J\I\
M2>']*\,^/_ASIVCV4=K;+=3G:G5CM7EB>2?<U[#7F/Q!_P"2I?#S_KYG_DM$
M=*D?5?E()?!+T?Z$WQR=E^&5S&"0LMS C8[C>#_2O0;2%(;""%% C2)44>@
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M;6XGU'4 N74-T5>X/(Z8//48K)EA\9?"F]L+_4/%$WB+0+BY6WNQ=JWF0E^
MREF8X_'\.<UD^/\ 2/#FC?%:?5?&ND3WF@ZK @ANHWD @F4 $$(03P.G/7CO
M55HOA#>ZK8:=X3\+SZ[J%S,J[$NKN!(ESR[,Y[=>F/<44OLOJWKUZZKRT_SN
M.I]I/:VGW;^>O^5C4^+WAG4[WQUX;N(/$MW;QZC=K;V\2!L6;@#,B8<<GVQ]
M:]CT.PN-*T.RL+J_EO[BWB$<EU+G=*1_$<DG)^IKSGXOWUMHVK>"=2O&:*RM
M-3WRR!2VQ0!Z<GI7:W7CGPY9:+IVL3ZD%L-1=8[680R'S&;.!@+D=#U HI_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX4+5QMLVU]R_K[GY7&[)][7_ !/?:*\Y\9^,=?T5]%\,Z';07_BG4(@7=_\
M5QA1\SD<=2#CH..G:N<O-:^*_@"%=8\23:;KNCJRBZ2U4*\"GC((1/7_ &A]
M.M%U?RO:_3^O,-;;:[VZGM-%>7_$GQYJNAVOA34/#C^?%J4XS!M7_259057)
M!*YSU&#6%KNJ_&+PM9/XFU*ZT>?3HMK3Z="@/E*2!R=H/XAS2OO?2SM\]/\
M,>^VMU<]MHJGI6H1ZMI%EJ,0Q'=0),H] P!Q^M7*IIIV8DTU=&1XIUS_ (1K
MPQJ.L_9_M/V.$R^3OV;\=LX./RKS.#XS>*KJWCGM_A7K,T,BATDC>5E93T((
M@P17:_%'_DF'B'_KS;^E7_ __(AZ!_V#X/\ T 5,=>9]K?BG_D-NUEWO^%C
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'+&21N4^XP1^%-TC2;'0M*M],TVW$%G;KMBC#%MHSGJ22>O<T0]WF_#YVO\
MD@DKM?UM>WYL\FU#Q%%XA^(&NZ+KWC.Z\,6.FNB6L%K=+:-/QDNTK#GJ/E]"
M*Y:\D\)0_%_PE;^'-1N-1>.[S=7<MT]P"6(VJK$D''S'C^]U->T^(OA]X4\5
MW*W.M:-#<W"@#S0[QN0.@+(02/K1_P *\\)BVL;>/1((H[&<7%OY+-&4D'\1
M92"WXDT4U;E;Z?COK_P J)R4DNOX;?Y'"?$"U^'?BCQ?-HWB26XT76+>!3%J
M,CI#'*AY #$D-CD?,!WP:P?"KS^$/B-HNA^'/&P\2:5>LRSVB-YB6T8'!R&9
M01ZC'3D5[)XB\'^'_%D*1ZYI<%X$X1VRKJ/0.I# ?0U'X=\$^&_">\Z'I,-H
M[C#2 L[D>FYB6Q[9HI^[_6^_W?UW"I[RLO\ ACB_"X_XR \9'_IS@_\ 04J?
MXC_\E!^'G_80D_DM=O:^'-)LO$%[KMO:;-2O46.XG\QSO5<8&TG:.@Z 4[4O
M#VEZOJ&G7]]:^;<Z=(9;5_,9?+8XR< @'H.N:(JRA_=M^O\ F$M>?S_R2_0X
M.3_DY"'_ + )_P#0S3OANH_X3_X@MCYO[009]L-7<GP[I1\2#Q";7_B:B#[,
M)_,;_5YSMVYV]>^,TNF^']+TB_U"^L;7RKG49!+=/YC-YC#H<$D#KVQ1'2WD
MFOO=PDKM^J?W*QP'B;_DO_@__KRG_D]4M+UFP\%?&;Q1!K]Q'90ZPL-Q:74Y
MVQL ,$%CP.2>OI7I5UX<TF\\06>NW%IOU*S1HX)O,<;%;.1M!VGJ>H->8?$O
MQ!#8>(9;/QMX075/"YC#V=[:1,)8F. P9]X Y]"O;K23Y>5?XOQ=_OV_(;CS
M7?\ A_ H_$WQGH6N^+/!VE:1?P7TD&JQ3RRV[AXU&X #<."3D]/2MOX@7UII
MOQA\"W=]=0VMM&ESOFF<(BY7 R3P.37)^';;2O&?B3P_!X-\*3Z5X?TR[%[=
M7MRN&E9>B[LMNY&/O'KVKVCQ'X0T#Q=;Q0:[IL=XD1)C)9D9,]<,I!'0=ZM)
MQ47VDW]ZM_PWIYDOWFUY6_&_]>IY[XLU6U\+?&/0O%&H2?\ $FOM/:S%T@W)
M&V20<CL01T[9JS\3_B%X8E\":AINGZM9ZE?:C%]G@@LY5F;+<9.TG&/>O09O
M#ND7.AQZ+<Z?#<:;%&L:03CS %487ELG(]>M8^A_#3P=X<OA>Z7H4$5TIRLK
MN\K(?5=[';^&*EQ37(]M?6U[V_X)2;3Y^NGI=*QP?B#39=,@^$^G7:_OK>ZB
M213V8(N1^!KM/BS_ ,DMU_\ Z]__ &85T&J>']+UF[T^ZO[7SI]/F\^U;S&7
MRW]< @'\<U-JVDV.NZ5<:9J4'GV=PNV6/>R[AUZJ01^!I5+SC)=6V_OM_D*F
MN22?9)?=?_,QO"=[::=\.-#N[ZZAM;:/3X"\T\@1%^11RQX%=%!/#=6\<]O*
MDT,BATDC8,K*>A!'!%8'B'P[:W/@6YT"UTT75N+=8(+0SE!QC;E\YP, GG/'
M>M/0=-.C^'].TUG$C6EM'"7'\150,_I6DY*4I2\_SN3%.,8Q_KH8/Q1_Y)AX
MA_Z\V_I5+P=XT\*VO@K1(+CQ-HT,T=C"CQR7\2LK!!D$%L@UU^J:79ZUI=QI
MNH0^=:7*%)8]Q7<OID$$?@:XO_A27P\_Z%[_ ,G;C_XY41NN;SM^%_\ ,MI.
MS[7_ !M_D<IX\\067Q)\1:'X.\.3K?0K=K=7]S#S&B+Z-T/!/3O@5M_%^PO+
M%-!\7Z;;M/+H%SYDT2]3"<;C^&!] 2:[K0O#&A^&;<P:+IEO9(V-QC7YFQ_>
M8\G\36J0&!! (/!!HM9+EW3O\_\ *V@MV^;:UOE_G?7[CD=*^*'@O5=.2\3Q
M%I]MN4%H;JX6&1#W!5B"?PS6)I/CR]\8_$B.S\,SA_#=A"QO[DPY6:0GY0A(
MR.GXC/L:U;_X2>!-2O#=W'AVW$I.3Y,DD2DYS]U& _2NHTO2-.T2Q6RTNR@L
M[93D1PH%&?7CJ?>J5K\S^X33MRK[R[7F/C[XC/9:]'X2T34-/L=2E7==:C?3
M+'%9H1_M'!?'('N/P].KC-6^%'@G7-5N-3U+1?/O+AM\LGVJ9=QQCHK@#IV%
M0U=KL7T?<I>#9O ?A:T-M9>*M(O-0NY-US=R:A$TUS(3W^;/4\"L?QEJ%MX0
M^,N@^(]18Q:;>V+V,L^"5C8'()_,?K6[;_!KP!:W,5Q#H&V6)PZ-]LG.&!R#
MR]=9J^BZ9K]@UCJUE#>6S')CE7(SZCT/N*IO526Z^ZUK6)2T<7L_OO>_Z'EW
MQ9\8:+K_ (7B\,Z%J=KJ6HZK<PQ)'9RK*%&\$EBI('0<=:ZOQ'XT@\!W>@6.
MH61&E70\B34?,(6W90,!E"G(/KD=#Z5=\/\ PY\)>%[S[7H^BPP7.,"5G>5E
M^A<G'X5NZEI=AK%C)9:E9PW=K)]Z*9 RG\#WHV6G>[^ZUOZZAN]>UOUN>?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)H8
MKF"2">-9(I%*NCC(8'@@BO*+SX("UO9I_"GB[5O#T<S%G@@9F0>PVNAQ]2:]
M:HI6UN%]+'!^#OA;IOA?4VUB\O[O6=;<8-[>-DKQSM!)QGU))]ZN>-_AWIOC
M7[-<R7-Q8:G:9^SWUL<.GL?4?D?>NPHIO6WD"TOYGENC?!F.+6+?4_%'B74?
M$DUJVZW2Z+!$/!&0SL3SVR![5U?B#PA_;OBGP[K7V[R/['E>3R?)W>=N &-V
MX;<8]#73T4[[>0K+7ST.:\<>$O\ A,M#CTW[;]CV7,=QYGE>9G8<XQD=?7-7
M?$^A?\))X6U#1/M/V?[7"8O.V;]F>^W(S^=;%%2XIIQZ/^OT'U3.(U;X>?VI
MX TKPM_:GE?8# ?M/V?=YGE_[.X8S]3CWKH?$FB_\)#X8U#1OM'V?[9;M#YV
MS?LR,9QD9_.M:BG+WKWZZL45RV:Z&3HFB_V-X5LM$^T>=]FM5M_.V;=V%QG;
MDX^F:YS1/AU_8WPUOO!_]J^=]J29?M?V?;M\S_8W'./K7<T42]YMOKO]]_S&
MERVMTV.,N?ASINI?#^P\*:E/),ME$BQ7<2^6ZNHP'49./IS7*Q_!._N9!;ZW
MX^UO4M)!!^PLSJ" > 29&'3CA1[8KUVBC[3EW%:R2./\5_#G1_%&D6%D&ETZ
M73@!97%H=KP  # ]1P/RZUS%A\%YY;Z"7Q3XSU;Q!:P.)([2<NL98?WMSOD=
M.F*]7HH6CO\ /Y]_4&DU8Y?7/!PUGQ=X>UX7H@&CF0BW$.[S=X ^]N&W&/0U
MG>-OAG8^+KZ'5;?4+K2-:@7;'?6APV.<;@""<9[$'WKN:*5M$NVOWC_X8\U\
M-?"&#3-<AUOQ!KU_XBU*W.;>2[+;8SV."S$D>YQ[5T<WA#SOB-;>+OMV/)L3
M9_9?)ZY).[?N]^F/QKIZ*J^WE^HK+7S.6\=>#?\ A--.L+3[?]C^R7J7>[R?
M,W;0?EQN&,YZU-XR\%:5XVTE;+4?,C>)O,M[F$XDA;U!_F*Z.BILK6\[_,=]
M;_(\DM_@E<7,Z1>(?&^LZQI<;!EL9&=5('0$EV'IT _"NN\7>!HO$\&AP0WB
MV$6DWD=RB+!O#!!@(/F&WZ\_2NMHJK[>3O\ ,3BG?ST^15U+3K35],N=.OHA
M-:W,9CE0]U->5_\ "DM1MV^RZ=\0M<M-'Z"Q#,<+W&0X7_QVO7J*FRO<=]+'
M,V/@NUT3P1-X:T*YFT_?"Z)>*295D8?ZPD$9;//!'X5I^'M,N=&T"STZ\U*;
M4KB!-KW<V=\IR3DY)/ZFM.BJO=M]Q))678****0PHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC=X;U72;@3VLNCS8.,%2"V58=B*47S-6V_X#?Z!+W4[[_P#!2_4]@I"0" 2
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MI<IF+?W9?D8<_3N>>U2^'_AKK.D_$"P\37^KQZC*+22.^GE9A))*V0-BXVA
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MK:2)@,94C(_2JLGP^^)GB&,Z9XI\:VC:*Y E2SB DE4'H2(TZ^Y/T-=+X\\
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MY5RGQ(\+7WC#PDVDZ?+;Q3FXBEW7#,JX5LGD G/X5UD:E(D4]0 *(Z1DO/\
M1?J-_$GY?J<'\3[0VMKI'BJ%&,^A7J3/M')@8A9!],$'\*P?'-K+XNN-=O=/
M._\ X1ZRC:S8#K<%EG8C_@"(/^!&O4]1L8=3TVZL+A=T-S$T3CU##!_G7/\
M@;PE)X7\+MIM]<+>74TCO<3\GS,\#KZ*%'X5-G9VZ:KU=O\ *_S&]T^^C]-_
MUL<L=27X@>,_"D,:EM/LK)=9N1CCS6&V)3]#N-8&IW&K2_'C5KBT\++XAFT^
MSB6VAEO([<0*0#O&\$$Y)''3-=W\.? ;>"+74DGN%N)KFX/EN&+;+=>(TY'&
M 3QTYJMXV^'EYK>LP>(_#>L-H^OP1^5YV,I,G96']<'Z=*IM*46MM7_X%_EH
MOR)46XM/R7W?YZO\SE?&-IXZ\7"PF7X<KI^HV5RD\-^NL6\CH <E>Q(/UKVA
M<E%W##8Y'O7E%C\.?&>O:C:3>/\ Q3!?V5G,)H[*R0*DC#D;R$3^1^HKUBFE
M:-O.X;ROY6/+/B2<?$[X=Y_Y_)?_ &2M+XV,%^$^L9(&3$!GO^]6KWQ$\#2>
M--/LFLM0;3]4T^;SK2X ) /<''/8<CTKCM3^&7CKQ/X:N[7Q1XJMKZ\"C[%;
MQCRK='R/GD98P6.,X!4\FLFFX./G?[VG^AHG:HI>27W7_P R'XFV<>H>$/A[
M9S#,4][:Q./4-'@_SKM?B5I5@OPJUNV6S@6"VLV>&,1@",J,@J.V*K^)_!&I
M:UIGA&VMI[1'T:[MY[@R.P#+&H!"84Y/IG%='XOT>XU_PAJVD6CQ)<7EL\,;
M2DA02.Y )Q^%76UA-+K)O\K?J9459POTBE_F>1^*9I)?@9X*M)6;[)>3VD-T
MV<?N\$X/Y#\J]9U?P[HMQX0N='EL;==,6W95B" +& #@CT(ZYK(3P%#J'POM
M/"&M.A:*U2)IK<DA)%Z,I('0^HKE;/X=?$&9/[&UGQK'<>'$79Y<2[9YD ^X
MS;=P!Z'YVXIUO>]I%=6W?Y?IT]2J?N\DGT5OQO\ \.<I:75Q:?LL3FV9@9+A
MHG*_W&F /YCC\:[+1-0\6Z9X;MM*LOA- ; 0JNW^V[;;*"/O,-O)/4YK:\)?
M#TZ?\,6\(>(#;W"RF42&V=BN&;((+ '(X/3J*YJ'P!\4M&1=+T3QU:_V.ORH
MUS%F:-/091N@Z88?A3F[RDN]O3:UG_5A15DGVO\ B[Z%KP3H6N:!X*\7V^JZ
M2=*M9C//96GVE)Q$C(<J&0]!@>E:'P,L+:T^%]A/#$BRW3R23.%Y<ARHR>^
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MS97]K%#$BLWF!EQG<,8QQV)JK)326R4OQ_JWR(U<7?>\?P?_  [^9RWP[_Y
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MU_J.IR:KK6HL&NKR08R!T51Z#_.,5V-4]$EV0ENWW9Y;\-O^2E?$/_K]B_\
M9Z3X=?\ (=^(_P#V$W_DU=!X2\(W^@^+_%6K74UL]OJ]PDL"Q,Q90-V=P*@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9F4,./3ZGM7.76LZ?X:_:'N[C6+J.RM[W2DCBGF;;'NR.K'@?=/)HB[RC?\
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M*)8U)# '/L<&LR?XB:KI'P3TOQ+-Y=YJ]X%B$DRA(][,PW,%P  ![5E?#?\
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MR12:Y"CHPR&!# @BJWAAG^&7CV7PE=R-_8&KN9])E<\12?Q1$_Y[>M7/C/\
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M9X! /0=0:U**.WE_7ZL??S,O7?#NE>)K*.SU>U^TP1RK,B>8R8=>ARI![UJ
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M^%O^$6_X1K^R_P#B3^;YOV?[1+][.<[MV[K[UC?\*2^'G_0O?^3MQ_\ '*]
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MW_\ 27]X.7+)3\G]ZV_-$OPAL9?"/B#6_!\[,V(;?4(2QY.] '[#HW'X5?\
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M]?A:.U0R2@Q2*X48R0I4,PY'0&MF[\5:+86^EW%S>^7%JDB16;>4Y\UG&5'
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M...E4_@CX'\/:AX$CU74]*M=0NKB61<W<2RB-5. %# @<Y/XU;5I22[1_/\
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MZDH:U7RI,N"< D;?ER1@;L9J>Z^(7A2Q.HB[UF& Z=*(;D2(ZE7P3M4$?.<
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MW_&X-7OYJWX-?J<I\2M&O_$'P^U;2],@\^\G11''O5=Q#J3RQ ' /4UD>(?
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M"Y5:WE;]3C_BCHFH^(OA[J6EZ5;_ &B]F\ORXMZIG#J3RQ Z ]ZL:B?$FD^
M;9/#^GV]WK<%O!&MM<.-A("A\G>HX&?XOSKJ**FVC7>WX#ZI]K_B0637+V%N
M]Y&L=TT2F9%Z*^/F Y/&<]S4]%%4W=B2LK!1112&%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M H"CGJ:Z"FME??\ X+_0?5A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111F@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ I*#TK.M=52[UB]L(X9#]D5-\W\&YAG;]0,$_446;O8#
M2HI!2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8W
MB14&E&>;4'LK>%@\TBRF/*]"-PY'7C'4X%-*[L!LBBL/PC<7EUX<MY[SS,N6
M,1F_UABS\A?_ &B,&MRB2L["3N%%%%(84444 %%%% !1110 4444 %%%% !2
M4M9FM:[I^@VOVC4)Q&AX50,LY]% ZFA)MV0F:5%<U'JGB+58O,T_2HK"(GB3
M47.\C_KFO3\6J2/2/$,DFZZ\3,BE>8[6RC4 _5PQJ^2WQ.W]>0K]CH:*YT^%
M'D<O+X@UIF/]VY"#\E %*/#VHVJ?Z%XDU!6SG%TJ3J?KD!OR84<L>X7?8Z$4
M5S\.KZAIMQ#:Z[!&%E8)'?6V?*+$X"L#RA)X[@\<UT J6K#3%HHHI#"BBB@
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M012)-$DL3!XW&Y6!R"#T-.IL4:0Q)%&H5$ 55 X ':DED2&-I)'5$4;F9C@
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MZBU76[@WITC18UGU(@&1W_U=LI_B?W]%[UF:EH5[I7AN^.DQM?:Y?8CFNI6
M<[N&8'L .@' X]*<(*ZYNO\ 7R$WV,CP;JVK^*O&%UJ5_:QI:V,+P1*J\12,
M1D9)R6P""?Y9KTJL;PSH4/AW0+;3HL%D7,K@??<]3_GM6S17G&4_=T2"*LM1
M:***R*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 )WI#3J2@#B9/!^L/K>IR0^(9K33;Z032)!&/.)Q@@.?NC&!Q^0KJ=+TN
MRT>Q2SL+=8(%Y"KW/J3W/O5VBJE4E)68DD@-85]X.T#4]0-]>Z;'-<'!9BS
M-@8&0#@\>HK=HI1E*+O%@U<;%&D4:QQHJ(H 55& !Z"GT"BD,**** "BBB@
MHHHH **** "BBB@ I.]+10!GG1M..K_VL;5/MVS8)N<A?Y5?&:**&[[@**0T
M4M(#!O/!_A_4-3.HW>EP37+8W,^2&QT)7.#^5;<:)&@1%"JHP !@ 4XT"J<F
MU9BT"L_6=&L]=T]K&^1G@9@Q56(S@YK0HI)M.Z&R*TM8+*U2VMHDBAC&$1!@
M**FH%% !1110 4444 %%%% %&/2;"'5)M2CM8Q>S($DFQEBHZ"KHZ444-WW
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV&AV\<^H3-%')((D*Q-(68@D#"@GH#1&+D[+<&TE=E^BN=_X3G0/^?BZ_P#
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M+C)^I7%)#_R/E[_V#+?_ -&S5NUS%UJ$&E>.R]YOCBO+&&&&3RV96D663*Y
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MJ'!)IRC9V>FO3;^NI2FW=1E=76OKN:FE7&H7%J3J=BEI<*Q7;',)%<?W@>"
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M-C4D)P,XY%1'V4U%."5^9?=MU+E[2',^9Z<K^_?H=[1117E'HA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 94GAZRF\3QZ_*&>[AMQ;Q9/RH,L2?J0Y%:M%%5*3E:[V$HI7
MMU"BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 54U%K]+0G38K>2Y)  N'*(!ZD@$_A5NBFG9W$U=6,K0]&&DZ#'I\D
MOFR$,T\H&-[N26/YDU:TO3;;1],M]/LU*V\";4!.3]2?4GFK=%5*<I7N]]1*
M$8VMT"BBBH*"BBB@ HHHH **** "BBB@ HHHH I/I5K)K,6JNK&ZAA,,9SPJ
MDY/'K5VBBFVWN))+8****0PHHHH **** "BBB@ HHHH **** *E]IMMJ+VC7
M*EOLEP+B( X&\*P!/TW$_E5NBBFVVK"LMPHHHI#"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@"O?6%KJ=G):7L"3V\GWD<9!JP  ,#@444[NUA65[A1112&%%%% %:UL+
M6R>X>V@6-[B0RRL.KL>Y-6:**;;>K$DEL%%%%(84444 %%%% !1110 4444
M%%%% !1110 4444 %5Y;"TFO8+V2!&N;<,(I2/F0,,$ ^]6**:;6PFD]PHHH
MI#"BBB@"*YMXKNUEMIUWPRH4=<D94C!'%+!!%:V\<$$:QQ1J%1%& H'0"I**
M=W:PK*]PHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKF/$6O7=C>K
M;V."8D\R?Y=V 2, ^G_UQ32N95JT:,.>1T]%9]QJ'_$BDU"V(/[GS$SSVZ&L
MW2?$9U#3;DR!%O((V?:!PP X('\Z.5DRQ%.,E!O5JZ.BHK-T*^FU+28[F<+Y
MC%@=HP.#BLW^U;W_ (3;^S_._P!%_P">>T?\\]W7&>M'*PEB(*,9=)62^9TE
M%<M8>*';6IK*]$:Q>8R1NHQ@@X&?K5L:Q<G5M4ML1^7:P&2/Y><@ \_G3Y61
M'&4I*Z?6WY_Y&]17+6.I^(;VQ^VP1V<L8)'E88,<>G;]:M7'B!G\-'4[1560
M,%9'YVG(!'ZT<K".+IN/-JM+[;KR-^BN=MKCQ+.L,ICL_*<*WOM/X^E17.K:
MS+K=U8Z?% XAP?G&#C [Y]Z.4'BXI)N+U\CIZ*YB+Q%=OI.H-+"D=[9D!AU4
MY..F?8TMM=^)KJVCGBCLBDBAESQP?QHY6)8R#MRIN^NB\[?F=-17.:UXAFTC
M6H("BM;-&'D&/FY)''Y58N]8D35]-@MVC>WNAN+8R2/:CE9;Q5.[5]4TOO-N
MBN9AU+6[^_U"&S-F%M92F) 02,D#I]*O:5K,EZMS;W,(@O;<'>@Z'W%#BQ0Q
M4).VNM[:;V_X8V**Y/3]4\1:G;&>VCM"@8K\PQS^=3ZQK>H:/!I[2)"TLH;S
MEQQQCH>W6CE=[$K&4^3VC32[V.EHK U'7V2TT^YL2C1W,FUMXR1ZCZU0UJ_\
M0:8TDYEB6U:8I%A5)QR1V]!0HMA4QE.";LVEV\]3KJ*R]'75QYW]JM&WW?+V
M8]\]/PJCXBUVYTB\MDA2-HW7<X8<GGL:5KNR-)8B,*?M9II?B=%17+ZUXK%M
M';C3S'(TB^8Q89"@]!]?\*GU;5[^WETZ*S$1DNEY#CC/'O[T^5D/&4ES6UM;
M;S.AHK(T]M=-V!?I;"#!R8^N>W>LS0_%9NI98M1,4>%+HZC XZC\N:.5C^M0
M3BI75^ZML=517+Z3XDN=2O[Q"D:PQPO+&,<\$8R?QJK!KOB"XL)+V.*U,$>=
MS'CH,GJ:.1D?7J32:N[WZ=MSLJ*YJ]\0W">&[74H$1999-C*RDCHV<?B*L6[
M^)3<Q>?'9B'>/,V]=N><<^E'*R_K4'+EBF]GHN^QNT5R_P#:NMW>J7MK8I;%
M;=ROSC!QDX[^U7]"U:?4&NK>[B6.YMFVOLZ'J/Z4.+00Q4)RY5?6_330V:*R
M==UAM+AB2&+S;J=ML2?Y^HK*EU3Q#I:K=7]O#);$@.$QE<_3_P"O0HMA4Q4*
M<G%WTWLMO4ZNBN>U?6;N*;3DTWRF%XN5,@ZYQCZ=:L6+:^;R,7L=J+?G>4Z]
M#COZXI<NEQK$Q<^1)OY::FS163XBU*?2]-%Q;A"YD"_.,C!!_P *;KVIW&FZ
M1'=0!/,9U!W#(Y!H2;*G7A#FO]E79L45BW&JW$6O:?9*$\J>/<^1SGGI^57M
M5NI++2[BYBV[XTRNX9%%AJM%J3_EW^ZY<HKC3KVO1Z>FH/#:FV/0]SSCIG-=
M=;S"XMHIP"HD0. >HR,T.+1-'$PJNT;]]5T)***HZJ-0-H!IK(L^\9+XQM[]
M?PI&LY<L6[7+U%<9:W_B6[N[BVBFA,EN</E5 _E[5M0:G<MXFDTYPGE)"'R!
MSG [_C5.-CGIXN$[:-7=M5UU_P C9HK%AU6XD\57&FD)Y$<89>/FSA3U_$UG
M6NJZ_J$EQ]D2U*12%#O&#_.CE8WBX+1)O5K1=MSJZ*K6!O#:*;X1BXR=PCZ=
M>*Q]1UF^DU1M,TF%'E09DD?HO^>*25RYUXPBI.^O3K]QT-%9&DR:T;B2/4XH
M?+505D0\D_A_]:DT'4[C4OMGGA!Y,NQ=HQQ18(UXR<59IN^Z[&Q16'K6LW%M
M=PZ?I\(EO)1GYNBC_(-4_P"V-7TFYA&L11-;2G;YD>/E/X4^5D3Q=.,G%WTW
M=M%ZLZBBN;U/5]4CUW^SM/2%R4# ./;)YS4VB:O>W6HW-A?Q1+-$N_,73MP>
M3ZBCE=K@L53=3V>N]MM+^IO45S'B/7;JQNT@L2,QIYDYV[@ 2  ?3_ZXK5NM
M3(T!]1ML9\H.H;D#V-+E8UB:;E*/\NYI453TJZDO=+M[F7;OD3+;1@5<I&T9
M*45)=0HKE-:\1W5GJ_E6HW6]OM\_Y<Y)/3/;CBM?6=2>ST5KZU*,3M*EAD$$
MC_&JY7H8+%4WS_W=_P#@&I17,_VGKMM8Q:C-#:3VK(LC+%D.JD9[_P#UZGN-
M=EAU+3F78=/O%&&(^8$\=?Q'ZT<K#ZW3MK=;;KOL_0WZ*Q;[5;E=?M-,M GS
M#=,S#.!_^H'\Q5#3]:O7UW5(9Y?,M[9)62/:H^ZP Y STHY6$L734N7SM\[7
M.IHKCK'4]=U)6N+:[LR0V/LC  X_+/ZUIZOK-U:SV^GV<*2W\J@G^ZOX?@>O
M2CE=[$QQD'#GL[>F_H;U%<N-8U?2;F$:Q%&UM*=OF1X^4_A4VJZMJ<6O1Z=8
M+ 3)'N'F#OR3SGT%'*Q_7*?+=IWNE:VNNQT5%<Y9ZMJC:A+I=Y'!'=&,O"Z@
ME<XSSSTJ.#Q2T6G7?VY$2^MV*B,# 8]OR/6CE8?7*773??RW7J=/15+2I+R7
M3XY;X()G&[:JXVCL/K5;Q!J<FFZ>#;_\?,KA(AC//?C_ #UI6UL:RJQC3]H]
MMS6HK(\.ZH^IZ>3.1]IB8I)QCZ''^>E4+/Q,QUZXL+P(L0E:.)P,8() !^M/
ME9'UJERQDWI+8Z:BL&+6+E]0U: B/9:1EH_EYR!WJI::EXAN].%_#'9RQ\_N
M\,'..O\ G-'*R7BX;)-[[+L[,ZFBJ.D:G'JU@MRB[#DJZ9SM8=OY4FLWXTW2
MYKD8W@80'NQZ?X_A2MK8V]K#V?M+Z6N7Z*P/#6KW&H"XM[T_Z5$V?N[<J?;V
M/\Q4!U?5-5OIX-(2%((3AII>Y_S[4^5W,OK=-PC-7=]EU.FHK$AU+4+'3;JX
MUB"-?)("&,\R?A^(Y_2J45YXFN[87T$5L(F^9(2/F9?7_)%'*#Q4596=][6U
M7J=117/ZEK=[:BTLX;9&U*=02@.53_//TQ58ZQK.D31-J\,;VLC;2\?53^%'
M*Q2QE.+L[Z;NVB]3J:*QWU2=?%$.GKL-N\6\G'.<'O\ A1<:G<1>*+33E">1
M+$7;(YSAN_\ P$4K,OZQ#\;?,V**YFT\3-_;UQ87FQ8A*T<3@8P0Q S]:E&I
M:E=W^J65MY0D@ \DD>XZY]LT^5D+%TY+W==6OFK_ .1T-%<8M_XE;4WT\30_
M:$7>1M7&..^/>K%[JFJ6FMZ59O.%\U8O/4(I#$N0><?RHY2%CH6NXM:VVZWM
MW.KHKF1XF:#Q%-8W806P?8K@8*GMGVJ[#JLS>);RPD\L6T$(D!QST4\G\31R
MLTCBJ4M$^MOGK_D;-%<K'JVN:N\DNEP11VJ-M4R8RWYUNZ7)?2V2MJ$*13Y(
MVJ>WJ:3C8JEB(U7:*=N]M"[16!XDUJXT=[,P*C+(6WAAU V]/3J:34_$#1Z7
M:7M@499I A#C...1]:?*R98JG%RBWK'<Z"BN;O=4U8Z_+IVGK;G8@<>8.V!G
MG/O4V?$KVLH86J397RRN.G.<YS[4<H?6HMM*+=K].QO45QEO?^)KF^GM(YH?
M-@^^"JX_E6O%JEY#XB33KP1^7+$&C91@EL<_R;]*'$F&,A+6S2O;5=3<HKF-
M/\0RW7B>:S9U-LQ9(A@=1WS[X/YT^'Q%(;C4YY AL;3Y4VCYG;.!S[X/YT<K
M&L92:O?JU]V_R.DHKE$U'Q-<V_VZ&VA$!&Y8L<LOKUS5F7Q$\OAI]1MD59D<
M(R-R <C^AHY6)8RFTVTUI?5;KR.BHKDFUK7K:QBU&:"U>U;:3MX.#^/%7[O7
M6@U>PB#1I:3P^:[..0,$]?P%'*QK&4VKNZVW7?9^AO45AZ;JE[J]_));HD>F
MQG =U.Z0^U;E)JQM3J1J+FCL%%%%(T"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"$+_  M/[CBM-TE-4DUR"5=K><&B<C[K9?\ 2HM&CNUN]66[5_.6T=&+#J0
M/QZ5W5%/G,E@(IQ:>JO\[W_*YPVBZ^^G:9]C2QFEGW$I@<$G]:GGTZ>Q\%3)
M.I\Z682LG]W) Q^E=E11S!'!/DY92O9-+3:_YG 6<VA6S6\S6>HF>(JQ( QN
M'/KTS5W['<7OBW4H[:]>T8("71<DC"\=17944<X1P-DHMZ)WT5NENC.8O-&C
MTKPSJ"I(\TTNUI)&'+'<.WXG\ZP[-]#BBA:>SU W" %BH&TL/3FO0Z*%,=3
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&BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
